DrugPatentWatch Database Preview
FOLIC ACID Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Folic Acid patents expire, and when can generic versions of Folic Acid launch?
Folic Acid is a drug marketed by Ben Venue, Fresenius Kabi Usa, Xgen Pharms, Amneal Pharm, Athem, Barr, Cadila Pharms Ltd, Chartwell Molecular, Contract Pharmacal, Everylife, Halsey, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, Jubilant Cadista, Lannett, Leading Pharma Llc, Lilly, Mk Labs, Nexgen Pharma Inc, Nuvo Pharms Inc, Pharmeral, Pioneer Pharms, Purepac Pharm, Qingdao Baheal Pharm, Sandoz, Sun Pharm Industries, Tablicaps, UDL, Usl Pharma, Valeant Pharm Intl, Vangard, Vintage, Vintage Pharms, Watson Labs, and Whiteworth Town Plsn. and is included in thirty-eight NDAs.
The generic ingredient in FOLIC ACID is folic acid. There are ten drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the folic acid profile page.
US ANDA Litigation and Generic Entry Outlook for Folic Acid
A generic version of FOLIC ACID was approved as folic acid by WATSON LABS on December 31st, 1969.
Summary for FOLIC ACID
| US Patents: | 0 |
| Applicants: | 36 |
| NDAs: | 38 |
| Suppliers / Packagers: | 24 |
| Bulk Api Vendors: | 119 |
| Patent Applications: | 7,185 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FOLIC ACID |
| Drug Sales Revenues: | Drug sales revenues for FOLIC ACID |
| DailyMed Link: | FOLIC ACID at DailyMed |
See drug prices for FOLIC ACID
Medical Subject Heading (MeSH) Categories for FOLIC ACID
Synonyms for FOLIC ACID
| (2S)-2-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid |
| (2S)-2-[(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid |
| (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid |
| (S)-2-(4-((2-amino-4-oxo-1,4-dihydropteridin-6-yl)methylamino)benzamido)pentanedioic acid |
| [3H]-folic acid |
| [3H]folic acid |
| 079F305 |
| 2d0k |
| 32108-06-8 |
| 4-Pteridinol, 2-amino-6-((p-((1,3-dicarboxypropyl)carbamoyl)anilino)methyl)- |
| 59-30-3 |
| 935E97BOY8 |
| A12227 |
| AC-11682 |
| Acfol (Spain) |
| Acide folique |
| Acide folique [INN-French] |
| Acido folico |
| Acido folico [INN-Spanish] |
| Acidum folicum |
| Acidum folicum [INN-Latin] |
| Acifolic |
| ACM32108068 |
| AI3-26387 |
| AKOS000503224 |
| AKOS015895671 |
| AKOS016007919 |
| Antianemia factor |
| ARONIS014410 |
| B03BB01 |
| BDBM50237629 |
| BDBM50367343 |
| BIDD:ER0563 |
| BIDD:GT0641 |
| Bio Science |
| bmse000299 |
| BP-13474 |
| BPBio1_000654 |
| BRD-K18673820-001-07-2 |
| BSPBio_000594 |
| BSPBio_002338 |
| C00504 |
| C19H19N7O6 |
| CAS-59-30-3 |
| CCG-38869 |
| CCRIS 666 |
| CHEBI:27470 |
| CHEMBL1622 |
| CPD000471860 |
| CTK8G0378 |
| Cytofol |
| D00070 |
| DB00158 |
| DivK1c_000494 |
| Dosfolat B activ |
| DSSTox_CID_2519 |
| DSSTox_GSID_22519 |
| DSSTox_RID_76606 |
| DTXSID0022519 |
| EINECS 200-419-0 |
| F0043 |
| Facid |
| Factor U |
| FOL |
| Folacid |
| Folacin |
| Folaemin |
| Folaemin [Netherlands] |
| Folan |
| Folasic (Australia) |
| Folate |
| Folbal |
| Folcidin |
| Folcidin (VAN) |
| Folcysteine |
| Foldine |
| Foldine [France] |
| Folettes |
| Foliamin |
| Folic |
| Folic acid (JP17/USP/INN) |
| Folic acid [BAN:INN:JAN] |
| Folic acid [INN:BAN:JAN] |
| Folic acid [USP:INN:BAN:JAN] |
| Folic Acid USP/BP |
| Folic acid, >=97% |
| Folic acid, 96-102%, pure |
| Folic acid, analytical standard |
| Folic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=97% |
| Folic acid, British Pharmacopoeia (BP) Reference Standard |
| Folic acid, European Pharmacopoeia (EP) Reference Standard |
| Folic acid, meets USP testing specifications |
| Folic acid, Pharmaceutical Secondary Standard; Certified Reference Material |
| Folic acid, tested according to Ph.Eur. |
| Folic acid, United States Pharmacopeia (USP) Reference Standard |
| Folic acid, USP grade |
| Folic acid, Vetec(TM) reagent grade, >=97% |
| Folic Acid,(S) |
| folic-acid |
| Folicare |
| Folicet |
| Folicet (TN) |
| Folico |
| Folico (Italy) |
| Folina |
| Folina (Italy) |
| Folipac |
| Folsaeure |
| Folsan |
| Folsaure |
| Folsav |
| Folvite |
| FT-0600598 |
| FT-0626515 |
| Glutamic acid, N-(p-(((2-amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-, l- |
| Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L |
| Glutamic acid, pteroyl-, l- |
| GS-6860 |
| GTPL4562 |
| GTPL4563 |
| HMS1921D20 |
| HMS2092N17 |
| HMS2096N16 |
| HMS2270L05 |
| HMS3259A05 |
| HMS3713N16 |
| HMS501I16 |
| HSDB 2002 |
| HY-16637 |
| IDI1_000494 |
| Incafolic |
| J10084 |
| KBio1_000494 |
| KBio2_001861 |
| KBio2_004429 |
| KBio2_006997 |
| KBio3_001558 |
| KBioGR_002222 |
| KBioSS_001861 |
| KS-00000F2X |
| Kyselina listova |
| Kyselina listova [Czech] |
| L-Glutamic acid, N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)- |
| L-Glutamic acid, N-(4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)- |
| L-Glutamic acid, N-(4-(((2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)- |
| L-Glutamic acid, N-(4-((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)- |
| L-Glutamic acid, N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- |
| L-glutamic acid, N-[4-[[(2-amino-4,8-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- |
| Lexpec |
| Liver Lactobacillus casei factor |
| LS-2157 |
| Megafol |
| MFCD00079305 |
| Millafol |
| Mission prenatal |
| Mittafol |
| MLS001304016 |
| MLS001335861 |
| MLS002548873 |
| N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid |
| N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid |
| N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid |
| N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid |
| N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid |
| N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid |
| N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid |
| N-[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoyl]-l-glutamic acid |
| N-{p-[(2-amino-4-hydroxypteridin-6-yl)methylamino]benzoyl}glutamic acid |
| N-pteroyl-L-glutamic acid |
| N2075 |
| Natur Flow |
| NC00455 |
| NCGC00016265-01 |
| NCGC00016265-02 |
| NCGC00016265-03 |
| NCGC00016265-04 |
| NCGC00016265-05 |
| NCGC00016265-08 |
| NCGC00142391-01 |
| NCGC00142391-03 |
| NCGC00254203-01 |
| Neocepri |
| Nifolin |
| Nifolin [Denmark] |
| NINDS_000494 |
| Novofolacid |
| Novofolacid [Canada] |
| NSC 3073 |
| NSC-3073 |
| NSC-758158 |
| NSC758158 |
| OVBPIULPVIDEAO-LBPRGKRZSA-N |
| PGA |
| PGA (VAN) |
| Pharmakon1600-01502020 |
| Preconceive |
| Prestwick_230 |
| Prestwick3_000627 |
| PteGlu |
| PteGlu;Vitamin M;Pteroyl-L-glutamic acid |
| Pteroyglutamic acid |
| Pteroyglutamicacid |
| Pteroyl-L-glutamate |
| Pteroyl-L-glutamic acid |
| Pteroyl-L-monoglutamate |
| Pteroyl-L-monoglutamic acid |
| Pteroylglutamate |
| Pteroylglutamic acid |
| Pteroylmonoglutamate |
| Pteroylmonoglutamic acid |
| Q127060 |
| Roche |
| s4605 |
| SAM002264616 |
| SBI-0051701.P002 |
| SC-20759 |
| SCHEMBL20791897 |
| SCHEMBL3876 |
| SDCCGMLS-0066738.P001 |
| Serum Folate Level |
| SMP2_000137 |
| SMR000471860 |
| SPBio_001357 |
| Spectrum_001381 |
| SPECTRUM1502020 |
| Spectrum2_001459 |
| Spectrum3_000749 |
| Spectrum4_001751 |
| Spectrum5_000602 |
| Tox21_111559 |
| Tox21_111559_1 |
| Tox21_300127 |
| UNII-935E97BOY8 |
| Usaf cb-13 |
| Vitamin B11 |
| Vitamin B9 |
| Vitamin Bc |
| Vitamin Be |
| Vitamin M |
| YEASTFOLATEPOLYGLUTAMATE |
| Z-4094 |
| ZINC8577218 |
US Patents and Regulatory Information for FOLIC ACID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vangard | FOLIC ACID | folic acid | TABLET;ORAL | 088730-001 | Mar 23, 1984 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Tablicaps | FOLIC ACID | folic acid | TABLET;ORAL | 083133-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Vintage | FOLIC ACID | folic acid | TABLET;ORAL | 040756-001 | Jun 4, 2010 | AA | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Udl | FOLIC ACID | folic acid | TABLET;ORAL | 088199-001 | Mar 29, 1983 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Ben Venue | FOLIC ACID | folic acid | INJECTABLE;INJECTION | 081066-001 | Dec 29, 1993 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
